| 发明名称 |
Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 摘要 |
The present invention relates to a new use of a statin drug in the improvement of diabetic neuropathy, specifically in improving nerve conduction velocity and nerve blood flow in patients suffering diabetes, in particular to pharmaceutical combinations of the statin drug and other agents known to improve diabetic neuropathy such as an aldose reductase inhibitor (ARI), an angiotensin converting enzyme (ACE) inhibitor or an angiotensin II (AII) antagonist which combinations are useful in the prevention and treatment of the complications of diabetes.
|
| 申请公布号 |
US2005209128(A1) |
申请公布日期 |
2005.09.22 |
| 申请号 |
US20040935747 |
申请日期 |
2004.09.08 |
| 申请人 |
THE UNIVERSITY COURT OF THE THE UNVERSITY OF ABERDEEN |
发明人 |
CAMERON NORMAN E.;COTTER MARY A. |
| 分类号 |
A61K45/00;A61K;A61K31/192;A61K31/196;A61K31/22;A61K31/235;A61K31/351;A61K31/40;A61K31/4045;A61K31/4184;A61K31/427;A61K31/4418;A61K31/505;A61K38/28;A61K38/55;A61K45/06;A61P;A61P3/10;A61P13/12;A61P25/28;A61P27/12;A61P43/00;(IPC1-7):A61K38/28;A61K31/506;A61K31/426;A61K31/401;A61K31/366;A61K31/225 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
